English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Streptococcus pneumoniae is a common cause of bacterial pneumonia especially in the elderly or those with significant comorbidities, and is also frequently associated with exacerbations of COPD (1, 2). Existing S. pneumoniae vaccines have partial strain coverage, may lack efficacy in high risk groups, and generally seem to have poorer efficacy against pulmonary compared to systemic infection (3,4). Hence alternative strategies to conventional vaccines maybe required to prevent the persisting high morbidity and mortality caused by S. pneumoniae lung infections.

Improving Pulmonary Immunity to Bacterial Pathogens through Streptococcus pneumoniae Colonization of the Nasopharynx